Rakuten Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.4M Buy
843,816
+95,870
+13% +$2.55M 0.05% 74
2025
Q4
$18.7M Buy
747,946
+662,360
+774% +$16.7M 0.06% 97
2025
Q3
$8.55M Buy
+85,586
New +$2.11M 0.03% 165
2025
Q1
$13.1M Buy
+519,963
New +$13.6M 0.06% 88
2024
Q3
$9.37M Buy
322,082
+80,066
+33% +$2.34M 0.05% 65
2024
Q2
$6.73M Buy
242,016
+89,477
+59% +$2.46M 0.04% 65
2024
Q1
$4.23M Buy
152,539
+138,576
+992% +$3.85M 0.03% 64
2023
Q4
$402K Buy
+13,963
New +$422K ﹤0.01% 61

Other funds holding PFE

Rakuten Investment Management's PFE Position: Q1 2026 in Review

Rakuten Investment Management increased its Pfizer (PFE) stake by 13% in Q1 2026, buying an estimated $2.55M and bringing the position to 843,816 shares worth $23.4M. The position accounts for 0.05% of the portfolio, ranked #74.

Rakuten Investment Management first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Rakuten Investment Management held 843,816 shares of Pfizer worth $23.4M as of Q1 2026.
  • Rakuten Investment Management bought 95,870 Pfizer shares in Q1 2026, an estimated $2.55M.
  • Pfizer made up 0.05% of Rakuten Investment Management's portfolio in Q1 2026, its #74 holding.
  • Rakuten Investment Management first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.